{"id":54574,"date":"2023-03-07T13:07:36","date_gmt":"2023-03-07T12:07:36","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/the-american-society-of-transplant-surgeons-position-statement-supports-use-of-caredxs-allosure-kidney-for-organ-transplant-surveillance\/"},"modified":"2023-03-07T13:07:36","modified_gmt":"2023-03-07T12:07:36","slug":"the-american-society-of-transplant-surgeons-position-statement-supports-use-of-caredxs-allosure-kidney-for-organ-transplant-surveillance","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/the-american-society-of-transplant-surgeons-position-statement-supports-use-of-caredxs-allosure-kidney-for-organ-transplant-surveillance\/","title":{"rendered":"The American Society of Transplant Surgeons Position Statement Supports Use of CareDx\u2019s AlloSure Kidney for Organ Transplant Surveillance"},"content":{"rendered":"<div>\n<p class=\"bwalignc\">\n<i>Statement Also Supports Use of AlloSure Heart and AlloMap Heart \u00a0<\/i>\n<\/p>\n<p>BRISBANE, Calif.&#8211;(BUSINESS WIRE)&#8211;CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers \u2013 today announced the issuance of a new position statement by the American Society of Transplant Surgeons (ASTS) supporting the use of CareDx\u2019s AlloSure\u00ae Kidney for organ transplant surveillance, and AlloSure Heart and AlloMap\u00ae Heart.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20230307005693\/en\/1498832\/4\/CareDx_Logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20230307005693\/en\/1498832\/21\/CareDx_Logo.jpg\"><\/a><\/p>\n<p>\nSpecifically, the new position statement, \u201cASTS Statement on donor-derived cell-free DNA (dd-cf-DNA)\u201d:\n<\/p>\n<ul class=\"bwlistdisc\">\n<li>\nSupports consideration of donor-derived cell-free DNA (dd-cfDNA), as in AlloSure Kidney, for surveillance in kidney transplant recipients to exclude subclinical antibody mediated rejection (ABMR).\n<\/li>\n<li>\nRecommends dd-cfDNA (AlloSure Kidney) for use in kidney transplant recipients experiencing acute allograft dysfunction to exclude rejection, particularly ABMR.\n<\/li>\n<li>\nRecommends that dd-cfDNA (AlloSure Heart) may be utilized to rule out subclinical rejection in heart transplant recipients.\n<\/li>\n<li>\nRecommends peripheral blood gene expression profiling (GEP), as in AlloMap Heart, as a non-invasive diagnostic tool to rule out acute cellular rejection in stable, low-risk, adult heart transplant recipients who are over 55 days status post heart transplantation.\n<\/li>\n<\/ul>\n<p>\n\u201cWe applaud ASTS for their leadership in issuing a position statement on the use of dd-cfDNA for routine monitoring of allograft health in kidney, and additionally the use of dd-cfDNA and peripheral blood gene expression profiling in heart,\u201d said Reg Seeto, CEO and President of CareDx.\n<\/p>\n<p>\nTo read the position statement, go <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fasts.org%2Fabout-asts%2Fposition-statements%23.ZAagv-yIZmA&amp;esheet=53357656&amp;newsitemid=20230307005693&amp;lan=en-US&amp;anchor=here&amp;index=1&amp;md5=0172ed1c668aa504b727f9771b2ab0e6\" rel=\"nofollow noopener\" shape=\"rect\">here<\/a>.\n<\/p>\n<p>\n<b>About CareDx \u2013 The Transplant Company<\/b>\n<\/p>\n<p>\nCareDx, Inc., headquartered in Brisbane, California, is a leading precision medicine solutions company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. CareDx offers testing services, products, and digital healthcare solutions along the pre- and post-transplant patient journey and is the leading provider of genomics-based information for transplant patients. For more information, please visit:<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.CareDx.com&amp;esheet=53357656&amp;newsitemid=20230307005693&amp;lan=en-US&amp;anchor=www.CareDx.com&amp;index=2&amp;md5=6c09541d0c5a80c7dac3578558e9d9fb\" rel=\"nofollow noopener\" shape=\"rect\">www.CareDx.com<\/a>.\n<\/p>\n<p>\n<b>Forward Looking Statements<\/b>\n<\/p>\n<p>\nThis press release includes forward-looking statements related to CareDx, Inc., including statements regarding the ASTS position statement and the potential benefits and results that may be achieved with CareDx\u2019s non-invasive testing services, AlloSure and AlloMap. These forward-looking statements are based upon information that is currently available to CareDx and its current expectations, speak only as of the date hereof, and are subject to risks and uncertainties that could cause actual results to differ materially from those projected, including risks that CareDx does not realize the expected benefits of its testing services; general economic and market factors; and other risks discussed in CareDx\u2019s filings with the SEC, including the Annual Report on Form 10-K for the fiscal year ended December 31, 2022 filed by CareDx with the SEC on February 27, 2023 and other reports that CareDx has filed with the SEC. Any of these may cause CareDx\u2019s actual results, performance, or achievements to differ materially and adversely from those anticipated or implied by CareDx\u2019s forward-looking statements. CareDx expressly disclaims any obligation, except as required by law, or undertaking to update or revise any such forward-looking statements.\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\n<b>CareDx, Inc.<\/b>\n<\/p>\n<p>\nMedia Relations<br \/>\n<br \/>Anna Czene<br \/>\n<br \/>818-731-2203<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#97;i&#x6c;&#116;o&#x3a;&#97;c&#x7a;&#101;n&#x65;&#64;c&#x61;&#x72;e&#x64;&#x78;&#46;&#x63;&#x6f;&#109;\" rel=\"nofollow noopener\" shape=\"rect\">&#x61;&#99;z&#x65;&#x6e;&#101;&#64;&#x63;&#x61;&#114;e&#x64;&#x78;&#46;c&#x6f;&#x6d;<\/a>\n<\/p>\n<p>\nInvestor Relations<br \/>\n<br \/>Greg Chodaczek<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;a&#x69;l&#x74;o&#x3a;i&#x6e;v&#x65;s&#x74;&#111;&#x72;&#64;&#x63;&#97;&#x72;&#101;&#x64;&#120;&#x2e;&#99;&#x6f;&#109;\" rel=\"nofollow noopener\" shape=\"rect\">i&#110;&#x76;&#x65;s&#116;&#x6f;&#x72;&#64;&#99;&#97;&#x72;&#x65;d&#120;&#x2e;&#x63;o&#109;<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Statement Also Supports Use of AlloSure Heart and AlloMap Heart \u00a0 BRISBANE, Calif.&#8211;(BUSINESS WIRE)&#8211;CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers \u2013 today announced the issuance of a new position statement by the American Society of &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/the-american-society-of-transplant-surgeons-position-statement-supports-use-of-caredxs-allosure-kidney-for-organ-transplant-surveillance\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-54574","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>The American Society of Transplant Surgeons Position Statement Supports Use of CareDx\u2019s AlloSure Kidney for Organ Transplant Surveillance - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/the-american-society-of-transplant-surgeons-position-statement-supports-use-of-caredxs-allosure-kidney-for-organ-transplant-surveillance\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"The American Society of Transplant Surgeons Position Statement Supports Use of CareDx\u2019s AlloSure Kidney for Organ Transplant Surveillance - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Statement Also Supports Use of AlloSure Heart and AlloMap Heart \u00a0 BRISBANE, Calif.&#8211;(BUSINESS WIRE)&#8211;CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers \u2013 today announced the issuance of a new position statement by the American Society of ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/the-american-society-of-transplant-surgeons-position-statement-supports-use-of-caredxs-allosure-kidney-for-organ-transplant-surveillance\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-07T12:07:36+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230307005693\/en\/1498832\/21\/CareDx_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-american-society-of-transplant-surgeons-position-statement-supports-use-of-caredxs-allosure-kidney-for-organ-transplant-surveillance\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-american-society-of-transplant-surgeons-position-statement-supports-use-of-caredxs-allosure-kidney-for-organ-transplant-surveillance\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"The American Society of Transplant Surgeons Position Statement Supports Use of CareDx\u2019s AlloSure Kidney for Organ Transplant Surveillance\",\"datePublished\":\"2023-03-07T12:07:36+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-american-society-of-transplant-surgeons-position-statement-supports-use-of-caredxs-allosure-kidney-for-organ-transplant-surveillance\\\/\"},\"wordCount\":537,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-american-society-of-transplant-surgeons-position-statement-supports-use-of-caredxs-allosure-kidney-for-organ-transplant-surveillance\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230307005693\\\/en\\\/1498832\\\/21\\\/CareDx_Logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-american-society-of-transplant-surgeons-position-statement-supports-use-of-caredxs-allosure-kidney-for-organ-transplant-surveillance\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-american-society-of-transplant-surgeons-position-statement-supports-use-of-caredxs-allosure-kidney-for-organ-transplant-surveillance\\\/\",\"name\":\"The American Society of Transplant Surgeons Position Statement Supports Use of CareDx\u2019s AlloSure Kidney for Organ Transplant Surveillance - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-american-society-of-transplant-surgeons-position-statement-supports-use-of-caredxs-allosure-kidney-for-organ-transplant-surveillance\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-american-society-of-transplant-surgeons-position-statement-supports-use-of-caredxs-allosure-kidney-for-organ-transplant-surveillance\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230307005693\\\/en\\\/1498832\\\/21\\\/CareDx_Logo.jpg\",\"datePublished\":\"2023-03-07T12:07:36+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-american-society-of-transplant-surgeons-position-statement-supports-use-of-caredxs-allosure-kidney-for-organ-transplant-surveillance\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-american-society-of-transplant-surgeons-position-statement-supports-use-of-caredxs-allosure-kidney-for-organ-transplant-surveillance\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-american-society-of-transplant-surgeons-position-statement-supports-use-of-caredxs-allosure-kidney-for-organ-transplant-surveillance\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230307005693\\\/en\\\/1498832\\\/21\\\/CareDx_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230307005693\\\/en\\\/1498832\\\/21\\\/CareDx_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-american-society-of-transplant-surgeons-position-statement-supports-use-of-caredxs-allosure-kidney-for-organ-transplant-surveillance\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"The American Society of Transplant Surgeons Position Statement Supports Use of CareDx\u2019s AlloSure Kidney for Organ Transplant Surveillance\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"The American Society of Transplant Surgeons Position Statement Supports Use of CareDx\u2019s AlloSure Kidney for Organ Transplant Surveillance - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/the-american-society-of-transplant-surgeons-position-statement-supports-use-of-caredxs-allosure-kidney-for-organ-transplant-surveillance\/","og_locale":"en_US","og_type":"article","og_title":"The American Society of Transplant Surgeons Position Statement Supports Use of CareDx\u2019s AlloSure Kidney for Organ Transplant Surveillance - Pharma Trend","og_description":"Statement Also Supports Use of AlloSure Heart and AlloMap Heart \u00a0 BRISBANE, Calif.&#8211;(BUSINESS WIRE)&#8211;CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers \u2013 today announced the issuance of a new position statement by the American Society of ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/the-american-society-of-transplant-surgeons-position-statement-supports-use-of-caredxs-allosure-kidney-for-organ-transplant-surveillance\/","og_site_name":"Pharma Trend","article_published_time":"2023-03-07T12:07:36+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230307005693\/en\/1498832\/21\/CareDx_Logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/the-american-society-of-transplant-surgeons-position-statement-supports-use-of-caredxs-allosure-kidney-for-organ-transplant-surveillance\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/the-american-society-of-transplant-surgeons-position-statement-supports-use-of-caredxs-allosure-kidney-for-organ-transplant-surveillance\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"The American Society of Transplant Surgeons Position Statement Supports Use of CareDx\u2019s AlloSure Kidney for Organ Transplant Surveillance","datePublished":"2023-03-07T12:07:36+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/the-american-society-of-transplant-surgeons-position-statement-supports-use-of-caredxs-allosure-kidney-for-organ-transplant-surveillance\/"},"wordCount":537,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/the-american-society-of-transplant-surgeons-position-statement-supports-use-of-caredxs-allosure-kidney-for-organ-transplant-surveillance\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230307005693\/en\/1498832\/21\/CareDx_Logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/the-american-society-of-transplant-surgeons-position-statement-supports-use-of-caredxs-allosure-kidney-for-organ-transplant-surveillance\/","url":"https:\/\/pharma-trend.com\/en\/the-american-society-of-transplant-surgeons-position-statement-supports-use-of-caredxs-allosure-kidney-for-organ-transplant-surveillance\/","name":"The American Society of Transplant Surgeons Position Statement Supports Use of CareDx\u2019s AlloSure Kidney for Organ Transplant Surveillance - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/the-american-society-of-transplant-surgeons-position-statement-supports-use-of-caredxs-allosure-kidney-for-organ-transplant-surveillance\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/the-american-society-of-transplant-surgeons-position-statement-supports-use-of-caredxs-allosure-kidney-for-organ-transplant-surveillance\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230307005693\/en\/1498832\/21\/CareDx_Logo.jpg","datePublished":"2023-03-07T12:07:36+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/the-american-society-of-transplant-surgeons-position-statement-supports-use-of-caredxs-allosure-kidney-for-organ-transplant-surveillance\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/the-american-society-of-transplant-surgeons-position-statement-supports-use-of-caredxs-allosure-kidney-for-organ-transplant-surveillance\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/the-american-society-of-transplant-surgeons-position-statement-supports-use-of-caredxs-allosure-kidney-for-organ-transplant-surveillance\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230307005693\/en\/1498832\/21\/CareDx_Logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230307005693\/en\/1498832\/21\/CareDx_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/the-american-society-of-transplant-surgeons-position-statement-supports-use-of-caredxs-allosure-kidney-for-organ-transplant-surveillance\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"The American Society of Transplant Surgeons Position Statement Supports Use of CareDx\u2019s AlloSure Kidney for Organ Transplant Surveillance"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/54574","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=54574"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/54574\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=54574"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=54574"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=54574"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}